Margaret Braxton Managing Director, Payer Strategy and Regulatory Research ACO REACH: Addressing Health Disparities with 5 Health Equity Centered Policies Health disparities have become a hot topic in the healthcare
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research Mental Health: Value Based Payment Models Continue to Evolve September 12, 2022 Bottom Line: Increased demand over the last decade in
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research Maternal Care: Value Based Payer Strategies to Reduce Costs August 5, 2022 Bottom Line: In proportion to the amount of American
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research Continued Scrutiny of PBMs Highlights Need for Value-Based Formulary Design July 15, 2022 Bottom Line: Due to bipartisan interest in addressing
Anesthesiology: What’s reality regarding payment outlook for anesthesiology? June 7, 2022 Bottom Line: The total payment made to anesthesiology groups (insurers, hospital subsidies, etc.) is very dependent on the state,
Oncology: Value Based Care Ideas Starting to Emerge May 2, 2022 Bottom Line: The main driver in value-based care for oncology providers is still via regimen of drug treatment plans
I/DD Shift Towards Value Based Payment Continues; Opportunities Abound for Providers April 8, 2022 Bottom Line: Payers are implementing more value-based care programs specifically for intellectual and development disabilities (I/DD), including
Elevating healthcare solutions through research and innovation on a global scale.